Uscom (UCM.AX) Stock Price

Uscom Price

ASX·CLOSED
0.01AUD+0.00 (+0.00 %)
Market closed

Over the last 19 years Uscom grew revenue by 2.2% annually, reaching 2.61 M AUD. For Uscom, the net margin of -126.5% is down versus -23.2% a few years ago. The stock trades about 9% above its 52-week low.

Uscom stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Uscom over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Uscom stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Uscom's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Uscom Stock Price History
DateUscom Price
7/10/20260.01 AUD
7/9/20260.01 AUD
7/8/20260.01 AUD
7/7/20260.01 AUD
7/6/20260.01 AUD
7/3/20260.01 AUD
7/2/20260.01 AUD
7/1/20260.01 AUD
6/30/20260.01 AUD
6/29/20260.01 AUD
6/26/20260.01 AUD
6/25/20260.01 AUD
6/24/20260.01 AUD
6/23/20260.01 AUD
6/22/20260.01 AUD
6/19/20260.01 AUD
6/18/20260.01 AUD
6/17/20260.01 AUD
6/16/20260.01 AUD
6/15/20260.01 AUD
6/12/20260.01 AUD
6/11/20260.01 AUD
6/10/20260.01 AUD
6/9/20260.01 AUD
6/5/20260.01 AUD
6/4/20260.01 AUD
6/3/20260.01 AUD
6/2/20260.01 AUD
6/1/20260.01 AUD
5/29/20260.01 AUD
5/28/20260.01 AUD
5/27/20260.01 AUD
5/26/20260.01 AUD
5/25/20260.01 AUD
5/22/20260.01 AUD
5/21/20260.01 AUD
5/20/20260.01 AUD
5/19/20260.01 AUD
5/18/20260.01 AUD
5/15/20260.01 AUD
5/14/20260.01 AUD
5/13/20260.01 AUD
5/12/20260.01 AUD
5/11/20260.01 AUD
5/8/20260.01 AUD
5/7/20260.01 AUD
5/6/20260.01 AUD
5/5/20260.01 AUD
5/4/20260.01 AUD
5/1/20260.01 AUD
4/30/20260.01 AUD
4/29/20260.01 AUD
4/28/20260.01 AUD
4/27/20260.01 AUD
4/24/20260.01 AUD
4/23/20260.01 AUD
4/22/20260.01 AUD
4/21/20260.01 AUD
4/20/20260.01 AUD
4/17/20260.01 AUD
4/16/20260.01 AUD
4/15/20260.01 AUD
4/14/20260.01 AUD
4/13/20260.01 AUD
4/10/20260.01 AUD
4/9/20260.01 AUD
4/8/20260.01 AUD
4/7/20260.01 AUD
4/2/20260.01 AUD
4/1/20260.01 AUD
3/31/20260.01 AUD
3/30/20260.01 AUD
3/27/20260.01 AUD
3/26/20260.01 AUD
3/25/20260.01 AUD
3/24/20260.01 AUD
3/23/20260.01 AUD
3/20/20260.01 AUD
3/19/20260.01 AUD
3/18/20260.01 AUD
3/17/20260.01 AUD
3/16/20260.01 AUD
3/13/20260.01 AUD
3/12/20260.01 AUD
3/11/20260.01 AUD
3/10/20260.01 AUD
3/9/20260.01 AUD
3/6/20260.01 AUD
3/5/20260.01 AUD
3/4/20260.01 AUD
3/3/20260.01 AUD
3/2/20260.01 AUD
2/27/20260.01 AUD
2/26/20260.01 AUD
2/25/20260.01 AUD
2/24/20260.01 AUD
2/23/20260.01 AUD
2/20/20260.01 AUD
2/19/20260.01 AUD
2/18/20260.01 AUD
2/17/20260.01 AUD
2/16/20260.01 AUD
2/13/20260.01 AUD
2/12/20260.01 AUD
2/11/20260.01 AUD
2/10/20260.01 AUD
2/9/20260.01 AUD
2/6/20260.01 AUD
2/5/20260.01 AUD
2/4/20260.01 AUD
2/3/20260.01 AUD
2/2/20260.01 AUD
1/30/20260.01 AUD
1/29/20260.01 AUD
1/28/20260.01 AUD
1/27/20260.01 AUD
1/23/20260.01 AUD
1/22/20260.01 AUD
1/21/20260.01 AUD
1/20/20260.01 AUD
1/19/20260.01 AUD
1/16/20260.01 AUD
1/15/20260.01 AUD
1/14/20260.01 AUD
1/13/20260.01 AUD
1/12/20260.01 AUD
1/9/20260.01 AUD
1/8/20260.01 AUD
1/7/20260.01 AUD
1/6/20260.01 AUD
1/5/20260.01 AUD
1/2/20260.01 AUD
12/31/20250.01 AUD
12/30/20250.01 AUD
12/29/20250.01 AUD
12/24/20250.01 AUD
12/23/20250.01 AUD
12/22/20250.01 AUD
12/19/20250.01 AUD
12/18/20250.01 AUD
12/17/20250.01 AUD
12/16/20250.01 AUD
12/15/20250.01 AUD
12/12/20250.01 AUD
12/11/20250.01 AUD
12/10/20250.01 AUD
12/9/20250.01 AUD
12/8/20250.01 AUD
12/5/20250.01 AUD
12/4/20250.01 AUD
12/3/20250.01 AUD
12/2/20250.01 AUD
12/1/20250.01 AUD
11/28/20250.01 AUD
11/27/20250.01 AUD
11/26/20250.01 AUD
11/25/20250.01 AUD
11/24/20250.01 AUD
11/21/20250.01 AUD
11/20/20250.01 AUD
11/19/20250.01 AUD
11/18/20250.01 AUD
11/17/20250.01 AUD
11/14/20250.01 AUD
11/13/20250.01 AUD
11/12/20250.01 AUD
11/11/20250.01 AUD
11/10/20250.01 AUD
11/7/20250.01 AUD
11/6/20250.01 AUD
11/5/20250.01 AUD
11/4/20250.01 AUD
11/3/20250.01 AUD
10/31/20250.01 AUD
10/30/20250.01 AUD
10/29/20250.01 AUD
10/28/20250.01 AUD
10/27/20250.01 AUD
10/24/20250.01 AUD
10/23/20250.01 AUD
10/22/20250.01 AUD
10/21/20250.01 AUD
10/20/20250.01 AUD
10/17/20250.01 AUD
10/16/20250.01 AUD
10/15/20250.01 AUD
10/14/20250.01 AUD
10/13/20250.01 AUD
10/10/20250.01 AUD
10/9/20250.01 AUD
10/8/20250.01 AUD
10/7/20250.01 AUD
10/6/20250.01 AUD
10/3/20250.01 AUD
10/2/20250.01 AUD
10/1/20250.01 AUD
9/30/20250.01 AUD
9/29/20250.01 AUD
9/26/20250.01 AUD
9/25/20250.01 AUD
9/24/20250.01 AUD
9/23/20250.01 AUD
9/22/20250.01 AUD
9/19/20250.01 AUD
9/18/20250.01 AUD
9/17/20250.01 AUD
9/16/20250.01 AUD
9/15/20250.01 AUD
9/12/20250.01 AUD
9/11/20250.01 AUD
9/10/20250.01 AUD
9/9/20250.01 AUD
9/8/20250.01 AUD
9/5/20250.01 AUD
9/4/20250.01 AUD
9/3/20250.01 AUD
9/2/20250.01 AUD
9/1/20250.01 AUD
8/29/20250.01 AUD
8/28/20250.01 AUD
8/27/20250.01 AUD
8/26/20250.01 AUD
8/25/20250.01 AUD
8/22/20250.01 AUD
8/21/20250.01 AUD
8/20/20250.01 AUD
8/19/20250.01 AUD
8/18/20250.01 AUD
8/15/20250.01 AUD
8/14/20250.01 AUD
8/13/20250.01 AUD
8/12/20250.01 AUD
8/11/20250.01 AUD
8/8/20250.01 AUD
8/7/20250.01 AUD
8/6/20250.01 AUD
8/5/20250.01 AUD
8/4/20250.01 AUD
8/1/20250.01 AUD
7/31/20250.01 AUD
7/30/20250.01 AUD
7/29/20250.01 AUD
7/28/20250.01 AUD
7/25/20250.01 AUD
7/24/20250.01 AUD
7/23/20250.01 AUD
7/22/20250.01 AUD
7/21/20250.01 AUD
7/18/20250.01 AUD
7/17/20250.01 AUD
7/16/20250.01 AUD
7/15/20250.01 AUD
7/14/20250.01 AUD
Access this data via the Eulerpool API
Get Free API Key

Uscom Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
2.84 M AUD
-1.97 M AUD
-1.96 M AUD
Jan 1, 2019
3.59 M AUD
-1.43 M AUD
-1.39 M AUD
Jan 1, 2020
4.00 M AUD
-1.28 M AUD
-1.33 M AUD
Jan 1, 2021
3.98 M AUD
-1.31 M AUD
-924,200.00 AUD
Jan 1, 2022
2.62 M AUD
-2.49 M AUD
-1.97 M AUD
Jan 1, 2023
2.72 M AUD
-2.86 M AUD
-2.59 M AUD
Jan 1, 2024
3.77 M AUD
-2.33 M AUD
-2.07 M AUD
Jan 1, 2025
2.61 M AUD
-3.32 M AUD
-3.30 M AUD

Uscom Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 12, 2026, 2:47 PM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
1.00–––1.001.002.003.002.003.003.003.002.002.003.002.00
––––––100.0050.00-33.3350.00––-33.33–50.00-33.33
200.00–––200.00100.00100.0066.67100.0066.67100.00100.00100.00100.00100.00100.00
2.002.002.002.002.001.002.002.002.002.003.003.002.002.003.002.00
-1.00-2.00-1.00-1.00-1.00-1.00-1.00-1.00-1.00-1.00-1.00–-1.00-2.00-2.00-3.00
–100.00-50.00––––––––––100.00–50.00
41.3546.1052.1261.1774.7181.6597.09111.72126.84138.87146.68149.56171.74173.34176.46182.14
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Uscom generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Uscom retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Uscom's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Uscom has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Uscom's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Uscom stock margins

The Uscom margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Uscom. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Uscom.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
78.69 %
-69.41 %
-69.02 %
Jan 1, 2019
80.86 %
-39.87 %
-38.70 %
Jan 1, 2020
89.12 %
-32.00 %
-33.30 %
Jan 1, 2021
87.80 %
-33.03 %
-23.24 %
Jan 1, 2022
86.87 %
-94.90 %
-75.16 %
Jan 1, 2023
84.60 %
-105.20 %
-95.27 %
Jan 1, 2024
83.80 %
-61.75 %
-54.99 %
Jan 1, 2025
86.65 %
-127.22 %
-126.46 %

Uscom Stock Revenue, EBIT, Earnings per Share

The Uscom earnings per share therefore indicates how much revenue Uscom has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.02 AUD
-0.02 AUD
-0.02 AUD
Jan 1, 2019
0.03 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2020
0.03 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2021
0.03 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2022
0.02 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2023
0.02 AUD
-0.02 AUD
-0.01 AUD
Jan 1, 2024
0.02 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2025
0.01 AUD
-0.02 AUD
-0.02 AUD

Uscom business model & stock analysis

Uscom Ltd is an Australian company that was founded in 2000. The company focuses on the development, manufacturing, and marketing of medical equipment and devices, with a focus on cardiovascular diagnostics. The company is headquartered in Sydney, Australia, and has branches in Europe, North America, and Asia. Uscom consists of a team of experienced scientists, engineers, and medical professionals who collaborate to manufacture and offer high-quality products that are recognized in the medical field worldwide. Uscom's business model is to develop innovative devices that help doctors and medical professionals diagnose and treat their patients more effectively. Over the years, the company has diversified its portfolio and now offers a variety of products that can be classified into different categories. One of Uscom's main divisions is the manufacturing of ultrasound devices that can be used to measure blood flow, blood pressure, and other important cardiovascular parameters. These devices are particularly useful in the diagnosis and monitoring of patients with cardiovascular diseases such as hypertension, heart failure, and stroke. Uscom also offers a range of devices specifically designed for use in intensive care units and emergency rooms. These devices include non-invasive blood pressure monitors, ventilators, and monitoring systems that enable quick and accurate patient monitoring. These devices are used by medical professionals worldwide to save lives and improve the treatment of critical illnesses. In addition to medical devices, Uscom also provides a variety of training and continuing education programs for medical professionals. These trainings include courses on device usage as well as general trainings on cardiovascular health and diagnosis. In recent years, Uscom has specialized in the development and marketing of telemedicine solutions. These solutions allow doctors and patients to communicate and exchange information remotely. This is particularly useful in providing care to patients in remote areas and in other situations where access to medical professionals is limited. One of Uscom's latest developments is a portable ultrasound Doppler device that can be used to measure blood flow, stroke volume, and other important cardiovascular parameters. This device is lightweight and easy to use, enabling doctors to diagnose patients quickly and accurately in any clinical setting. Overall, Uscom has established a good reputation in the medical industry and is considered a leading company in cardiovascular diagnostics. The company continues its efforts to develop innovative products and solutions that can improve the lives of patients worldwide.

Uscom SWOT Analysis

Strengths

  • Uscom Ltd has a strong and experienced management team that possesses extensive knowledge and expertise in the industry.
  • The company has a portfolio of innovative and high-quality products that are in demand in the market.
  • Uscom Ltd has established strong relationships with key suppliers and partners, allowing for timely delivery and competitive pricing.

Weaknesses

  • The company heavily relies on a limited number of major customers for a significant portion of its revenue, creating vulnerability to shifts in their buying patterns or economic downturns.
  • Uscom Ltd currently lacks geographic diversification, primarily operating in a single market, making it susceptible to local market conditions and regulatory changes.
  • The company has a limited budget for research and development, hindering the introduction of new and innovative products.

Opportunities

  • Uscom Ltd can capitalize on the growing demand for its products in emerging markets, where there is a rising need for advanced medical devices and technologies.
  • The company can explore strategic partnerships or acquisitions to expand its product offerings and enter new market segments.
  • The increasing focus on healthcare and medical advancements globally provides opportunities for Uscom Ltd to showcase its expertise and gain a competitive edge.

Threats

  • Intense competition from established players in the industry poses a threat to Uscom Ltd's market share and profitability.
  • Potential changes in regulations or policies within the healthcare sector could impact the demand for Uscom Ltd's products or increase compliance costs.
  • Economic downturns or fluctuations in exchange rates might adversely affect the company's financial performance and expansion plans.

Uscom Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Uscom historical P/E ratio, EBIT multiple, and P/S ratio

Uscom annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Uscom shares outstanding

The number of shares of Uscom was 182.14 M in 2025. This indicates how many shares Uscom is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
126.84 M Stocks
Jan 1, 2019
138.87 M Stocks
Jan 1, 2020
146.68 M Stocks
Jan 1, 2021
149.56 M Stocks
Jan 1, 2022
171.74 M Stocks
Jan 1, 2023
173.34 M Stocks
Jan 1, 2024
176.46 M Stocks
Jan 1, 2025
182.14 M Stocks
Price targets and forecasts for Uscom are not yet available.

Uscom shareholder structure

% Name
36.11719%
Phillips (Robert Allan)
Phillips (Robert Allan)
21.12499%
Meng (Xianhui)
Meng (Xianhui)
6.77815%
Neja Pty. Ltd.
Neja Pty. Ltd.
3.21243%
Jetan Pty. Ltd.
Jetan Pty. Ltd.
1.62557%
Bozwald Pty. Ltd.
Bozwald Pty. Ltd.
1.49104%
Cameron (Douglas James)
Cameron (Douglas James)

Uscom Executives and Management Board

AP

Assoc. Prof. Robert Phillips

Chief Executive Officer, Chief Scientist, Executive Chairman of the Board · since 2011

Compensation543,815.00 AUD
NS

Mr. Nick Schicht

General Manager

Compensation341,497.00 AUD
BC

Mr. Brett Crowley

Company Secretary, Non-Executive Director · since 2016

Compensation38,454.00 AUD
CB

Mr. Christian Bernecker

Non-Executive Independent Director

Compensation38,325.00 AUD
MX

Mr. Meng Xianhui

Non-Executive Director

Uscom Supply Chain

Uscom Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#Name1M3M6M1Y2YTrend
1
Citigroup
Supplier
-0.16
0.48
0.64
0.82
—

Frequently asked questions about Uscom

The main competitors of Uscom Ltd in the market include global medical device companies such as Edwards Lifesciences Corporation, Masimo Corporation, and Nonin Medical Inc. These companies also specialize in developing and manufacturing medical devices and technologies, particularly focused on cardiovascular care and continuous non-invasive monitoring. Uscom Ltd competes with these industry leaders by offering unique and innovative products, such as its non-invasive hemodynamic monitoring systems. As Uscom Ltd continues to expand its market presence and enhance its product offerings, it aims to effectively compete with these key players in the medical device market.

All fundamentals and in-depth analysis of Uscom

Our stock analysis for Uscom stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Uscom. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Uscom Stock
Uscom Revenue→
Uscom Stock
Uscom Net Income→
Uscom Stock
Uscom P/E→
Uscom Stock
Uscom P/S→
Uscom Stock
Uscom EBIT→
Uscom Stock
Uscom Dividend→
Uscom Stock
Uscom Directors Dealings→
Uscom Stock
Uscom Stocks→
Uscom Stock
Uscom Market capitalization→
Uscom Stock
Uscom Debt→
Uscom Stock
Uscom Liabilities→
Uscom Stock
Uscom Equity→
Uscom Stock
Uscom AAQS→
Uscom Stock
Uscom Employees→
Uscom Stock
Uscom ROE→
Uscom Stock
Uscom ROA→
Uscom Stock
Uscom ROCE→
Uscom Stock
Uscom News→
Uscom Stock
Uscom Analyst Price Targets→

Health Stocks

Utah Medical ProductsUS Stem CellVaccinexUS Physical TherapyVaidya Sane Ayurved LaboratoriesUrtesteVaishali PharmaUrogen PharmaValbiotisUpstream BioValerio TherapeuticsUpHealthAll Stocks A–Z →